Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Tempra Blizz - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Tempra Blizz

Approved

STANDARD

Tempra Blizz

DHG Pharmaceutical Joint-Stock Company🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 15a4c471f6e55fb1
Company: DHG Pharmaceutical Joint-Stock Company
Type: Standard

Approval Details

Approval Id: 15a4c471f6e55fb1
Drug Approval Philippines Name: Tempra Blizz
Product Name: Tempra Blizz
Registration Number: DR-XY48911
Brand Name: Tempra Blizz
Generic Name: Paracetamol
Dosage Form: Effervescent Tablet (Orange Flavor)
Dosage Strength: 500 mg
Manufacturer: DHG Pharmaceutical Joint-Stock Company
Importer: Taisho Pharmaceuticals (Philippines), Inc.
Distributor: Taisho Pharmaceuticals (Philippines), Inc.
Issuance Date: 26 October 2023
Expiry Date: 26 October 2028
Classification: Over-the-Counter (OTC) Drug

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

15a4c471f6e55fb1

Type

Standard

Back to Philippines FDA Approvals